Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IR vs GSK✓SelectedUSD · GSKIR vs GSK performance historyLatest closeAs of-2.79%11/20
Stock and ETF performance explorer

IR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+301.3%
GSK return
+71.7%
Excess return
+229.7%
Maximum drawdown
-50.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-0.1%-2.7%-2.8%
7D-7.9%-5.3%-2.6%-6.2%
30D-0.9%-3.7%+2.7%+0.2%
3M-1.3%-7.3%+6.0%+0.9%
6M+11.3%-4.2%+15.6%+12.3%
YTD-1.1%+0.9%-1.9%-1.9%
1Y+5.1%+7.3%-2.1%+2.1%
3Y+11.5%+52.7%-41.2%-7.1%
5Y+28.2%+40.1%-12.0%+8.8%
All+301.3%+71.7%+229.7%+213.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling